Literature DB >> 12381689

Radiographically diagnosed antral gastritis: findings in patients with and without Helicobacter pylori infection.

S Dheer1, M S Levine, R O Redfern, D C Metz, S E Rubesin, I Laufer.   

Abstract

The purpose of this study was to characterize the radiographic findings of antral gastritis and to determine whether there are differences in the appearance of antral gastritis in patients with and without Helicobacter pylori infection. A search of radiology, endoscopy and pathology files revealed 90 patients with antral gastritis on double contrast upper gastrointestinal tract studies who had endoscopy with testing for H. pylori. The barium studies were evaluated to further characterize the findings of antral gastritis without knowledge of the H. pylori status of the patients or of the endoscopy or pathology findings. The radiographic findings of antral gastritis included thickened folds in 67 patients (74%), polypoid antral gastritis (a subset of patients with thickened folds) in 6 (9%), antral erosions in 21 (23%), enlarged areae gastricae in 14 (16%), crenulation of the lesser curvature in 4 (4%), mucosal nodularity in 2 (2%), a hypertrophied antral-pyloric fold in 2 (2%) and antral striae in 1 (1%). 43 patients (48%) with antral gastritis were H. pylori positive and 47 patients (52%) were H. pylori negative. Thickened folds were detected in 39 H. pylori-positive patients (91%) with antral gastritis vs 28 H. pylori-negative patients (60%) (p<0.001); polypoid gastritis in 6 H. pylori-positive patients (14%) vs 0 H. pylori-negative patients (p<0.05); enlarged areae gastricae in 14 H. pylori-positive patients (33%) vs 0 H. pylori-negative patients (p<0.0001); and antral erosions in 2 H. pylori-positive patients (5%) vs 19 H. pylori-negative patients (40%) (p<0.0001). Our experience suggests that antral gastritis caused by H. pylori infection is associated with characteristic features on double contrast studies (including thickened folds, polypoid gastritis and enlarged areae gastricae) and that this condition is rarely associated with antral erosions. Thus, radiologists can often suggest whether the patient's gastritis is caused by H. pylori on the basis of radiographic findings.

Entities:  

Mesh:

Year:  2002        PMID: 12381689     DOI: 10.1259/bjr.75.898.750805

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  8 in total

1.  Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation.

Authors:  Nobutake Yamamichi; Chigaya Hirano; Masao Ichinose; Yu Takahashi; Chihiro Minatsuki; Rie Matsuda; Chiemi Nakayama; Takeshi Shimamoto; Shinya Kodashima; Satoshi Ono; Yosuke Tsuji; Keiko Niimi; Yoshiki Sakaguchi; Yosuke Kataoka; Itaru Saito; Itsuko Asada-Hirayama; Chihiro Takeuchi; Seiichi Yakabi; Hikaru Kaikimoto; Yuta Matsumoto; Daisuke Yamaguchi; Natsuko Kageyama-Yahara; Mitsuhiro Fujishiro; Ryoichi Wada; Toru Mitsushima; Kazuhiko Koike
Journal:  Gastric Cancer       Date:  2015-10-20       Impact factor: 7.370

2.  Detection of gastritis by a deep convolutional neural network from double-contrast upper gastrointestinal barium X-ray radiography.

Authors:  Ren Togo; Nobutake Yamamichi; Katsuhiro Mabe; Yu Takahashi; Chihiro Takeuchi; Mototsugu Kato; Naoya Sakamoto; Kenta Ishihara; Takahiro Ogawa; Miki Haseyama
Journal:  J Gastroenterol       Date:  2018-10-03       Impact factor: 7.527

3.  Correlation between the ABC classification and radiological findings for assessing gastric cancer risk.

Authors:  Takahiro Itoh; Miho Saito; Nagaaki Marugami; Toshiko Hirai; Aki Marugami; Junko Takahama; Toshihiro Tanaka; Kimihiko Kichikawa
Journal:  Jpn J Radiol       Date:  2015-08-07       Impact factor: 2.374

4.  Comparative analysis of upper gastrointestinal endoscopy, double-contrast upper gastrointestinal barium X-ray radiography, and the titer of serum anti-Helicobacter pylori IgG focusing on the diagnosis of atrophic gastritis.

Authors:  Nobutake Yamamichi; Chigaya Hirano; Yu Takahashi; Chihiro Minatsuki; Chiemi Nakayama; Rie Matsuda; Takeshi Shimamoto; Chihiro Takeuchi; Shinya Kodashima; Satoshi Ono; Yosuke Tsuji; Mitsuhiro Fujishiro; Ryoichi Wada; Toru Mitsushima; Kazuhiko Koike
Journal:  Gastric Cancer       Date:  2015-07-30       Impact factor: 7.370

5.  The Role of Conventional Ultrasonography in the Evaluation of Antrum Wall Thickness in Obese Patients.

Authors:  Fatih Mehmet Yazar; Murat Baykara; Mustafa Karaağaç; Ertan Bülbüloğlu
Journal:  Obes Surg       Date:  2016-12       Impact factor: 4.129

6.  Mucosal patterns of Helicobacter pylori-related gastritis without atrophy in the gastric corpus using standard endoscopy.

Authors:  Sheng-Lei Yan; Shwu-Tzy Wu; Chien-Hua Chen; Yeh-Huang Hung; Tsung-Hsun Yang; Vun-Siew Pang; Yung-Hsiang Yeh
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

7.  Postprandial fullness correlates with rapid inflow of gastric content into duodenum but not with chronic gastritis.

Authors:  Nobutake Yamamichi; Takeshi Shimamoto; Chihiro Minatsuki; Yoko Yoshida; Mitsuhiro Fujishiro; Shinya Kodashima; Jun Kato; Osamu Goto; Satoshi Ono; Keiko Niimi; Yu Takahashi; Maki Konno-Shimizu; Masao Ichinose; Kazuhiko Koike
Journal:  BMC Gastroenterol       Date:  2011-12-21       Impact factor: 3.067

8.  Associated factors of atrophic gastritis diagnosed by double-contrast upper gastrointestinal barium X-ray radiography: a cross-sectional study analyzing 6,901 healthy subjects in Japan.

Authors:  Nobutake Yamamichi; Chigaya Hirano; Takeshi Shimamoto; Chihiro Minatsuki; Yu Takahashi; Chiemi Nakayama; Rie Matsuda; Mitsuhiro Fujishiro; Maki Konno-Shimizu; Jun Kato; Shinya Kodashima; Satoshi Ono; Keiko Niimi; Satoshi Mochizuki; Yosuke Tsuji; Yoshiki Sakaguchi; Itsuko Asada-Hirayama; Chihiro Takeuchi; Seiichi Yakabi; Hikaru Kakimoto; Ryoichi Wada; Toru Mitsushima; Masao Ichinose; Kazuhiko Koike
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.